XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Information (Tables)
3 Months Ended
Dec. 31, 2025
Segment Information  
Schedule of significant expense categories

​

​

​

​

​

​

​

​

​

​

Three months ended December 31, 

​

​

2025

​

2024

Revenues, net

​

$

(1,207,833)

​

$

—

Cost of revenues

​

​

29,626

​

​

—

Gross profit

​

​

(1,237,459)

​

​

—

Operating expenses:

​

​

​

​

​

​

Research and development expenses

​

​

​

​

​

​

ONS-5010/LYTENAVA development

​

​

2,594,912

​

​

8,725,849

Compensation and related benefits

​

​

614,534

​

​

569,127

Stock-based compensation

​

​

97,818

​

​

110,029

Other research and development

​

​

327,088

​

​

255,145

​

​

​

3,634,352

​

​

9,660,150

Selling, general and administrative expenses

​

​

​

​

​

​

Professional fees

​

​

1,247,517

​

​

2,321,458

Compensation and related benefits

​

​

914,465

​

​

2,780,189

Stock-based compensation

​

​

783,332

​

​

3,562,391

Europe launch expenses

​

​

4,800,734

​

​

2,466,342

Facilities, fees and other related costs

​

​

866,093

​

​

816,322

​

​

​

8,612,141

​

​

11,946,702

​

​

​

​

​

​

​

Segment loss from operations

​

​

(13,483,952)

​

​

(21,606,852)

Other segment items (i)

​

​

(9,574,183)

​

​

38,984,466

Segment loss before income taxes

​

$

(23,058,135)

​

$

17,377,614